Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
Nippon India Nifty Pharma ETF |
[Equity: Index] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
-0.10 |
Equity |
100.01 |
Trep |
0.09 |
|
|
Concentration Analysis |
Top 5 Holdings |
61.81% |
Top 10 Holdings |
80.73% |
Top 25 Holdings |
100.00% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
100.01 |
Cash |
-0.01 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
4.69 |
PE Ratio |
31.04 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
Sun Pharmaceutical Industries Limited |
23.74 |
DIVI LABORATORIES LTD |
11.02 |
Cipla Limited |
10.82 |
Dr Reddys Laboratories Limited |
10.02 |
Lupin Limited |
6.21 |
Torrent Pharmaceuticals Limited |
4.36 |
Aurobindo Pharma Limited |
4.21 |
Mankind Pharma Limited |
3.66 |
Alkem Laboratories Limited |
3.56 |
Laurus Labs Limited |
3.13 |
Zydus Lifesciences Limited |
3.05 |
Glenmark Pharmaceuticals Limited |
2.88 |
IPCA Laboratories Limited |
2.60 |
Abbott India Limited |
2.08 |
Biocon Limited |
1.99 |
Gland Pharma Limited |
1.66 |
J B Chemicals and Pharma Ltd |
1.58 |
Ajanta Pharma Limited |
1.39 |
Natco Pharma Limited |
1.04 |
Granules India Limited |
1.01 |
Triparty Repo |
0.09 |
Net Current Assets |
-0.10 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
 |
|
|
|
|